Phaseline

Targets › IRON

IRON: drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 4; Hematology.

Open in Phaseline: the race on IRON, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
PharmanutraSucrosomial® Iron (Sideral® Forte)
Dietary iron supplement with sucrosomial delivery technology
IRONPhase 4Anemia–

Conditions

Anemia (1)

Modalities

small molecule (1)

Companies

Pharmanutra (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.